Please assess the completion status of the following clinical trial:

Trial Title: Early Inhaled Nitric Oxide for Respiratory Failure in Newborns

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infants born at \>34 weeks gestational age~* Require assisted ventilation for hypoxic respiratory failure~* Have a diagnosis of primary persistent pulmonary hypertension (PPHN), respiratory distress syndrome, perinatal aspiration syndrome, pneumonia/sepsis, or suspected pulmonary hypoplasia~* Have an oxygenation index \>15 and \<25 based on 2 arterial blood gases taken at least 15 minutes apart or an Fi02 \>80%~* In-dwelling arterial line~* Parental consent~Exclusion Criteria:~* Known structural congenital heart disease, except patent ductus arteriosus and atrial level shunts~* Congenital diaphragmatic hernia~* Use of high frequency jet ventilation at the time of randomization~* Prior exposure to inhaled nitric oxide therapy

- Gender: ALL
- Minimum Age: None
- Maximum Age: 14 Days
- Healthy Volunteers: f

Study Arms:
- Early iNO Management (Type: EXPERIMENTAL): Initiation of iNO in use for term and near-term infants in respiratory failure with an oxygenation index between 15-25.
- Standard iNO management (Type: ACTIVE_COMPARATOR): Begin a sham initiation of iNO in term and near-term infants in respiratory failure with an oxygenation index (OI) between 15-25; initiated actual iNO therapy based on standard threshold (OI \>=25).

Based on this trial design, predict the completion outcome and termination type (if applicable).